BIT:PHNPersonal Products
Pharmanutra (BIT:PHN) Stock Price Cools As Revenue Growth Meets Earnings Drift
Pharmanutra’s stock has been cooling for weeks, with the share price down about 14% over three months and a rich P/E near 36x that asks investors to pay up for the story. The latest quarter has given that premium a fresh stress test. Revenue reached €41.0m and net income hit €6.5m, solid figures that keep the growth narrative alive but come against a backdrop of a share price already trading above a discounted cash flow estimate of €64.01. The tension between strong reported progress and an...